Shuttle Pharmaceuticals Holdings, Inc. reported earnings results for the full year ended December 31, 2023. For the full year, the company reported net loss was USD 6.59 million compared to USD 3.03 million a year ago. Basic loss per share from continuing operations was USD 0.44.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.41 USD | +7.84% |
|
-6.67% | -9.89% |
06-18 | Shuttle Pharmaceuticals Names Timothy Lorber as Chief Financial Officer | MT |
06-18 | Shuttle Pharmaceuticals Holdings, Inc. Announces Chief Financial Officer Changes | CI |
1st Jan change | Capi. | |
---|---|---|
-9.89% | 6.39M | |
+53.92% | 803B | |
-7.27% | 351B | |
+17.80% | 324B | |
+10.68% | 303B | |
+16.58% | 243B | |
+2.25% | 228B | |
+10.64% | 217B | |
+6.70% | 164B | |
-4.19% | 155B |
- Stock Market
- Equities
- SHPH Stock
- News Shuttle Pharmaceuticals Holdings, Inc.
- Shuttle Pharmaceuticals Holdings, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023